Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion

doi:10.3748/wjg.v23.i41.7415

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8909)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

545

WORD

309

HTML

4650

Figures (1-1)

252

Tables (1-5)

241

Sum=5997

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1044

Download

1868

Sum=2912

Nov 7, 2017 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (65)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 7, 2017; 23(41): 7415-7424
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival and recurrence-free survival curves of hepatocellular carcinoma patients who either underwent liver resection alone or followed by postoperative adjuvant transcatheter arterial chemoembolization. A: OS for HCC/MVI (-) patients (P = 0.872); B: OS for HCC/MVI (+) patients (P = 0.019); C: RFS for HCC/MVI (-) patients (P = 0.974); D: RFS for HCC/MVI (+) patients (P = 0.002). OS: Overall survival; HCC: Hepatocellular carcinoma; MVI: Microvascular invasion; RFS: Recurrence-free survival.

Citation: Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424
URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7415.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7415